scholarly article | Q13442814 |
P2093 | author name string | L V Rao | |
G M Vallaro | |||
M L Snyder | |||
P2860 | cites work | Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high-performance liquid chromatography with ultraviolet detection | Q30687115 |
Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients | Q33423496 | ||
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine | Q34048732 | ||
The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography | Q34122803 | ||
Human alpha-1-glycoprotein and its interactions with drugs | Q34331335 | ||
Clinical trial-based cost-effectiveness analyses of antipsychotic use. | Q36675837 | ||
Measurement of clozapine and norclozapine in plasma/serum by high performance liquid chromatography with ultraviolet detection | Q36702286 | ||
Clozapine-induced seizures and EEG changes | Q42282305 | ||
Simultaneous analysis of clozapine, clomipramine and their metabolites by reversed-phase liquid chromatography. | Q43616083 | ||
Determination of clozapine and its N-desmethyl metabolite by high-performance liquid chromatography with ultraviolet detection | Q43630883 | ||
Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography. | Q43703592 | ||
Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection | Q43794493 | ||
Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine | Q43978248 | ||
Direct-injection high performance liquid chromatography ion trap mass spectrometry for the quantitative determination of olanzapine, clozapine and N-desmethylclozapine in human plasma | Q44060212 | ||
Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis. | Q44263492 | ||
Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa) | Q44399803 | ||
Determination of clozapine and its metabolite, norclozapine in various biological matrices using high-performance liquid chromatography | Q46929746 | ||
High throughput therapeutic drug monitoring of clozapine and metabolites in serum by on-line coupling of solid phase extraction with liquid chromatography-mass spectrometry | Q46983458 | ||
[Determination of clozapine and its N-demethylated metabolite in serum by gas chromatography-mass spectrometry with selected ion monitoring]. | Q52415439 | ||
Simultaneous determination of the antipsychotic drugs levomepromazine and clozapine and their main metabolites in human plasma by a HPLC-UV method with solid-phase extraction | Q56995912 | ||
Serum concentrations of clozapine determined by nitrogen selective gas chromatography | Q67023481 | ||
Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection | Q67931630 | ||
Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection | Q67982487 | ||
Determination of clozapine in human serum by capillary gas chromatography | Q68068344 | ||
Rapid and sensitive determination of clozapine in human plasma using high-performance liquid chromatography and amperometric detection | Q69752308 | ||
Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection | Q70624976 | ||
Clozapine-induced EEG abnormalities and clinical response to clozapine | Q70885169 | ||
A rapid gas chromatographic method quantitating clozapine in human plasma or serum for the purpose of therapeutic monitoring | Q70940143 | ||
Column liquid chromatographic determination of clozapine and N-desmethylclozapine in human serum using solid-phase extraction | Q71030625 | ||
Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma | Q71840605 | ||
On-line fully automated determination of clozapine and desmethylclozapine in human serum by solid-phase extraction on exchangeable cartridges and liquid chromatography using a methanol buffer mobile phase on unmodified silica | Q72273028 | ||
Determination of clozapine and its major metabolites in human plasma and red blood cells by high-performance liquid chromatography with ultraviolet absorbance detection | Q73230442 | ||
Automated determination of clozapine and major metabolites in serum and urine | Q73602213 | ||
Analysis of clozapine and norclozapine by high-performance liquid chromatography | Q73764505 | ||
Assay for quantitation of clozapine and its metabolite N-desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection | Q73964647 | ||
Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection | Q77392437 | ||
[The determination of clozapine in blood and urine by gas chromatography-mass spectrometry] | Q78194233 | ||
P433 | issue | 6 | |
P921 | main subject | liquid chromatography-tandem mass spectrometry | Q117788892 |
P304 | page(s) | 394-398 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Journal of Clinical Laboratory Analysis | Q15754724 |
P1476 | title | Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum | |
P478 | volume | 23 |
Q45877250 | Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry |
Q33751539 | Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis |
Q53081839 | Sensitive quantification of clozapine and its main metabolites norclozapine and clozapine-N-oxide in serum and urine using LC-MS/MS after simple liquid-liquid extraction work-up. |
Search more.